New Decade, Old Debate: Blocking the Cytokine Pathways in Infection-Induced Cytokine Cascade
Objectives:. Our understanding of the immunopathogenesis of coronavirus disease 2019 is evolving; however, a “cytokine storm” has been implicated. Ongoing clinical trials are evaluating the value of anticytokine therapies to treat patients with coronavirus disease 2019. This review summarizes the ex...
Main Authors: | Mahrukh S. Rizvi, MD, Alice Gallo De Moraes, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-03-01
|
Series: | Critical Care Explorations |
Online Access: | http://journals.lww.com/10.1097/CCE.0000000000000364 |
Similar Items
-
Cytokine production and signaling pathways in respiratory virus infection
by: Hirokazu eKimura, et al.
Published: (2013-09-01) -
The Imperfect Cytokine Storm
by: Vinh Q. Chau, MD, et al.
Published: (2020-07-01) -
Cytokines Are at the Heart of It
by: Anna B. Catino, MD
Published: (2020-06-01) -
659 Blocking cytokine IL-1 with anakinra for the prevention of cytokine release syndrome in COVID-19
by: Jason Williams, et al.
Published: (2020-11-01) -
INTERACTION OF CYTOKINE CASCADE WITH PSYCHOLOGICAL PROFILE IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. A. Shalenkova, et al.
Published: (2014-07-01)